Cargando…
787. The Addition of Avibactam Augments the Activity of Piperacillin Against Mycobacterium abscessus in vitro, and Is Effective in Treating M. abscessus Infection in a Galleria mellonella in vivo Model
BACKGROUND: Mycobacterium abscessus is an emerging multi-drug-resistant pathogen, harboring the β-lactamse Bla(MAB). Avibactam is a non-β-lactam, β-lactamase inhibitor shown to inhibit Bla(MAB) and improve the efficacy of ampicillin for M. abscessus infections in in vitro and in vivo models. Whether...
Autores principales: | Meir, Michal, Barkan, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253713/ http://dx.doi.org/10.1093/ofid/ofy210.794 |
Ejemplares similares
-
The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model
por: Meir, Michal, et al.
Publicado: (2018) -
Virulence-Associated Secretion in Mycobacterium abscessus
por: Bar-Oz, Michal, et al.
Publicado: (2022) -
Alternative and Experimental Therapies of Mycobacterium abscessus Infections
por: Meir, Michal, et al.
Publicado: (2020) -
Mycobacterium abscessus – to treat or not to treat
por: Pang, Yong-Kek, et al.
Publicado: (2013) -
786. Ceftaroline and Avibactam? Is This a Potential Combination for Mycobacterium abscessus Infection?
por: Dousa, Khalid M, et al.
Publicado: (2018)